ENDRA Life Sciences (NDRA) Current Leases (2019 - 2026)
ENDRA Life Sciences (NDRA) reported Current Leases of $133953.0 for Q1 2026, up 6.23% year-over-year from $126097.0 in Q1 2025, and up 3.54% quarter-over-quarter from $129378.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Current Leases (2019 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 8 years of Current Leases data on file, last reported at $133953.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $133953.0, up 6.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $133953.0 (up 6.23% YoY), and the FY2025 annual result was $129378.0, up 33.47% from the prior year.
- Current Leases advanced to $133953.0 in Q1 2026 per NDRA's latest filing, from $129378.0 in the prior quarter.
- Over five years, Current Leases peaked at $187339.0 in Q3 2024 and troughed at $96937.0 in Q4 2024.
- A 5-year average of $149008.6 and a median of $147057.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2024: Current Leases jumped 73.18% in 2022, then tumbled 44.24% in 2024.
- A 5-year view of Current Leases shows it stood at $152228.0 in 2022, then increased by 14.21% to $173857.0 in 2023, then plunged by 44.24% to $96937.0 in 2024, then surged by 33.47% to $129378.0 in 2025, then rose by 3.54% to $133953.0 in 2026.
- Business Quant data shows NDRA's Current Leases at $133953.0 in Q1 2026, $129378.0 in Q4 2025, and $128791.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 53.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | - |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | - |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | 133,953.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 133,953.00 |
| Dec 31, 2025 | 129,378.00 |
| Sep 30, 2025 | 128,791.00 |
| Jun 30, 2025 | 128,218.00 |
| Mar 31, 2025 | 126,097.00 |
| Dec 31, 2024 | 96,937.00 |
| Sep 30, 2024 | 187,339.00 |
| Jun 30, 2024 | 182,733.00 |
| Mar 31, 2024 | 178,239.00 |
| Dec 31, 2023 | 173,857.00 |
| Sep 30, 2023 | 168,610.00 |
| Jun 30, 2023 | 163,013.00 |
| Mar 31, 2023 | 157,554.00 |
| Dec 31, 2022 | 152,228.00 |
| Sep 30, 2022 | 147,057.00 |
| Jun 30, 2022 | 142,025.00 |
| Mar 31, 2022 | 137,117.00 |
| Dec 31, 2021 | 132,330.00 |
| Sep 30, 2021 | 127,696.00 |
| Jun 30, 2021 | 123,192.00 |